The concurrent increase of circulating levels of sclerostin increase with the decrease of glomerular filtrate rate could also have an extraosseous origin such as vascular calcification, a prevalent condition of bone and mineral disorders associated to CKD (MBD-CKD). Here, SOST is linked to chronic kidney disease.